 |
|
Why Aren't We Using More Niacin?
James V. Felicetta, MD;
Carl T. Hayden
Arch Fam Med. 1994;3(4):324-326.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. JAMA. 1984;251:351-374.
FREE FULL TEXT
2. Friek MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med. 1987;317:1237-1245.
PUBMED
3. Blankenhorn DH, Nession SA, Johnson RL, Sanmarco ME, Azem SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987;257:3233-3240.
FREE FULL TEXT
4. Cashin-Hemphill L, Mack WJ, Pagocla J, et al. Beneficial effects of colestipol-niacin on coronary atherosclerosis: a 4-year follow-up. JAMA. 1990;264:3013-3024.
FREE FULL TEXT
5. Brown BG, Albers JJ, Fisher ID, et al. Regression of coronary artery disease as a result of aggressive lipid lowering in men with high levels of apoliproprotein B. N Engl J Med. 1990;323:1289-1298.
PUBMED
6. Wysowski DK, Kennedy DL, Gross TP. Prescribed use of cholesterol-lowering drugs in the United States, 1978 through 1988. JAMA. 1990;263:2185-2188.
FREE FULL TEXT
7. Altschul R, Hoffer A, Stephen JD. Influence of nicotinic acid on serum cholesterol in man. Arch Biochem Biophys. 1955:54:558-559.
PUBMED
8. Parsons WB, Achor RW, Berge KG, McKenzie BF, Barker NW. Changes in concentration of blood lipids following prolonged administration of large doses of nicotinic acid to persons with hypercholesterolemia: preliminary observations. Proc Mayo Clin. 1956:31:377-390.
9. O'Reilly PD, Demay M, Katlowski K. Cholesteremia and nicotinic acid. Arch Intern Med. 1957:100:797-800.
FREE FULL TEXT
10. Achor RW, Berge KG, Barker NW, McKenzie BF. Treatment of hypercholesterolemia with nicotinic acid. Circulation. 1958:17:497-504.
FREE FULL TEXT
11. Galbraith PA, Perry WF, Beamish RE. Effect of nicotinic acid on serum-lipids in normal and atherosclerotic subjects. Lancet. 1959;1:222-223.
PUBMED
12. The Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease. JAMA. 1975;231:360-381.
FREE FULL TEXT
13. Canner PL, Berge KG, Wenger NK, et al. Fifteenyear mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986;8:1245-1255.
ABSTRACT
14. Carlson LA, Rosenhamer G. Reduction of mortality in the Stockholm lschemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand. 1988;233:405-418.
15. The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med. 1988;148:36-69.
FREE FULL TEXT
16. The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel ll). JAMA. 1993;269:3015-3023.
FREE FULL TEXT
17. Gotto AM Jr, Breen WJ, Corder CN, et al. Once-daily, extended-release gemfibrozil in patients with dyslipidemia: The Lopid SR Work Group I. Am J Cardiol. 1993;71:1057-1063.
PUBMED
18. Etchason JA, Miller TD, Squires RW, et al. Niacin-induced hepatitis: a potential side effect with low-dose time-release nicotinic acid. Ann Intern Med. 1989:111:253-255.
FREE FULL TEXT
19. Henkin Y, Oberman A, Hurst DC, Segrest JP. Niacin revisited: clinical observations on an important but underutilized drug. Am J Med. 1991;91:239-246.
PUBMED
20. Schechtman G, Hiatt J, Hartz A. Evaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium, and lovastatin) for treating hypercholestorelemia in veterans. Am J Cardiol. 1993;71:759-765.
PUBMED
|
